RecruitingNCT06382233

The PRO-FUTURE Project

PRecocious biOmarkers oF Unilateral ureTero-pelvic jUnction obstRuction in childrEn


Sponsor

University of Campania Luigi Vanvitelli

Enrollment

85 participants

Start Date

Jan 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about specific biomarkers of unilateral ureteropelvic junction obstruction (UPJO) in children undergoing surgical intervention for unilateral UPJO compared with controls. The main question it aims to answer are: * Are Urinary single-cell and extracellular vesicles (EVs) screening useful to stage the intrarenal injury and repair processes in UPJO babies? * Do babies with unilateral UPJO have a whole blood gene expression profiling (WBGEP) allowing an accurate unilateral UPJO diagnosis?


Eligibility

Min Age: 1 DayMax Age: 5 Years

Inclusion Criteria2

  • unilateral UPJO
  • years of age

Exclusion Criteria5

  • bilateral UPJO
  • previous surgical intervention on the urinary tract
  • bladder or lower urinary tract symptoms or malformations
  • nephro- or urolithiasis, vesicoureteral reflux
  • urinary tract infections.

Interventions

DIAGNOSTIC_TESTIdentification of Diagnostic Biomarkers

Urinary single-cell and EVs screening to stage the intrarenal injury and repair processes in UPJO babies and identification of the whole blood gene expression profiling of babies with unilateral UPJO. Data deriving from patients with unilateral UPJO will be compared with data deriving from controls.


Locations(5)

Univeristà degli Studi della Campania Luigi Vanvitelli

Naples, Campania, Italy

Department of Clinical Sciences and Community Health, University of Milano

Milan, Italy

Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico

Milan, Italy

Obstetrics and Gynecology Unit, University of Modena and Reggio Emilia

Modena, Italy

AORN Santobono-Pausilipon

Naples, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06382233


Related Trials